A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.